Titlebook: Chronic and Acute Leukemias in Adults; Clara D. Bloomfield Book 1985 Springer Science+Business Media Dordrecht 1985 Staging.adjuvant thera

panorama

定點

Surface Marker Analysis of Acute Myeloblastic Leukemia,to therapy. This is particularly true of acute myeloblastic leukemias (AML) which are traditionally classified into subgroups by morphology and cytochemical staining patterns [1, 2]. For the most part, however, classification of AML by morphology has not been successful in predicting outcome of dise

可忽略

Classification of 358 Cases of Acute Myeloid Leukemia by FAB Criteria: Analysis of Clinical and Mor1,2]. Since its introduction, the FAB classification has been widely accepted internationally because of its underlying logic and relative ease of application. It has served as the basis for classification in several studies evaluating the results of chemotherapy in acute myeloid leukemia (AML) [3–8

Pert敏捷

HUMID

Post-Remission Therapy for Acute Myelogenous Leukemia,this success. These include the introduction of new drugs, the use of combination chemotherapy, a better understanding of the biology of the disease and bone marrow regeneration, improved supportive care including platelet and granulocyte transfusions and more effective antibiotics. As a result, com

Wernickes-area

The Role of Marrow Transplantation in the Treatment of Leukemia,unately, the dose of systemic chemotherapy or radiotherapy that can be given with safety is limited by toxicity to normal tissues, and for many agents the most sensitive targets are the hematopoietic cells of the marrow.